Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,992
  • Shares Outstanding, K 50,998
  • Annual Sales, $ 5,820 K
  • Annual Income, $ -12,980 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.69
  • Price/Sales 2.92
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.40
  • Most Recent Earnings $-0.56 on 05/30/25
  • Next Earnings Date 08/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.13
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +87.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1634 +109.61%
on 06/18/25
0.4350 -21.26%
on 06/25/25
-0.0074 (-2.11%)
since 06/10/25
3-Month
0.1634 +109.61%
on 06/18/25
1.2200 -71.93%
on 04/23/25
-0.4446 (-56.49%)
since 04/10/25
52-Week
0.1634 +109.61%
on 06/18/25
2.3099 -85.17%
on 03/07/25
-1.5575 (-81.97%)
since 07/10/24

Most Recent Stories

More News
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary

PSTV : 0.3415 (-3.20%)
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing

PSTV : 0.3415 (-3.20%)
Plus: Q1 Earnings Snapshot

Plus: Q1 Earnings Snapshot

PSTV : 0.3415 (-3.20%)
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

PSTV : 0.3415 (-3.20%)
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PSTV : 0.3415 (-3.20%)

Business Summary

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.4202
2nd Resistance Point 0.3976
1st Resistance Point 0.3752
Last Price 0.3415
1st Support Level 0.3302
2nd Support Level 0.3076
3rd Support Level 0.2852

See More

52-Week High 2.3099
Fibonacci 61.8% 1.4899
Fibonacci 50% 1.2366
Fibonacci 38.2% 0.9834
Last Price 0.3415
52-Week Low 0.1634

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar